Drugs / Fortrans®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03562884 Comparator | Jul 2018 → Apr 2019 | — | Ipsen | Completed | No outcome recorded |
| Phase 3 | NCT02321462 Comparator | Mar → Dec 2015 | — | Ipsen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fortrans | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03562884 ↗ |
| Route | Oral | “Fortrans® solution administered orally” NCT02321462 ↗ |